IL9 and B-cell chronic lymphocytic leukemia: IL-9 released at abnormally high levels in the TME of CLL acts on stromal cells by enhancing their secretion of homing chemokines, which in turn favor leukemic cell accumulation in the pro-survival and chemoprotective lymphoid niche (74, 122).